0 Комментарии
0 Поделились
114 Просмотры
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Marketplace
-
Offers
-
Jobs
-
Courses
-
Игры
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Rare Disease Treatment Market Growth and Future Forecast"Executive Summary Rare Disease Treatment Market Value, Size, Share and Projections The global rare disease treatment market size was valued at USD 7.02 billion in 2024 and is projected to reach USD 15.11 billion by 2032, with a CAGR of 10.10% during the forecast period of 2025 to 2032. Being a comprehensive in nature, Rare Disease Treatment Market report undeniably meets the...0 Комментарии 0 Поделились 1Кб Просмотры
-
Ultomiris Drug Market: Revolutionizing Rare Disease Treatment with Next-Generation TherapyThe Ultomiris Drug Market is witnessing remarkable growth as healthcare advances bring new hope to patients suffering from rare and life-threatening diseases. Ultomiris (ravulizumab-cwvz), developed by Alexion Pharmaceuticals (a subsidiary of AstraZeneca), is a next-generation complement inhibitor that has redefined the management of diseases such as Paroxysmal Nocturnal...0 Комментарии 0 Поделились 1Кб Просмотры
-
What Rare Disease Treatment Developments Are Expanding the Metagonimiasis Treatment Market?Executive Summary Metagonimiasis Treatment Market: Share, Size & Strategic Insights CAGR Value The global metagonimiasis treatment market size was valued at USD 320.50 billion in 2025 and is expected to reach USD 431.92 billion by 2033, at a CAGR of3.80% during the forecast period The Metagonimiasis Treatment report makes available a thoughtful overview of product specification,...0 Комментарии 0 Поделились 132 Просмотры
-
CNS Antisense Oligonucleotide Market Strategic Outlook 2031CNS specific antisense oligonucleotides are short, synthetic strands of nucleic acids designed to selectively bind to RNA targets within the central nervous system. By modulating gene expression, these therapies can reduce or alter the production of disease-causing proteins. Their ability to precisely target genetic mutations makes them highly promising for neurodegenerative and rare genetic...0 Комментарии 0 Поделились 486 Просмотры
-
Crigler-Najjar Syndrome Treatment: Orphan Drug Research at 5.60% CAGR to 2032"Key Drivers Impacting Executive Summary Crigler-Najjar Syndrome Treatment Market Size and Share The global Crigler-Najjar Syndrome treatment market size was valued at USD 150.50 million in 2024 and is expected to reach USD 232.72 million by 2032, at a CAGR of 5.60% during the forecast period The Crigler-Najjar Syndrome Treatment Market report contains...0 Комментарии 0 Поделились 566 Просмотры
© 2026 Thunder Hoodie Social
Russian